tirzepatide 2024 and Injectable Semaglutide Correlated with Greatest Weight Loss Among GLP-1 Medications How Does Tirzepatide Work? |

Inject subcutaneously, not intramuscularly

Data Availability No datasets were generated or analysed during the current study

Compounded semaglutide from FDA-registered 503B pharmacies following USP-797 standards can be safe, though compounded medications are not FDA-approved

Microdosing protocols can be adapted to address these specific needs

Adults with overweight or obesity who were dispensed tirzepatide or semaglutide for type 2 diabetes treatment from May 2022 to September 2023 had a baseline weight measurement available within 60 days before the first medication dispense and had not used a GLP-1 receptor agonist in the past were included